<p>The protective effect of WR-1065 against the side effects of Adriamycin was studied in tumor bearing mice. It has been noticed that WR-1065 pretreatment improved the Adriamycin toxicities such as increased enzyme levels, pathological lesions in lung, liver and heart and increased rate of lipid peroxidation, without reducing its anticancer property. © 1994.</p>
cited By 4
Dr. Damodaran Vasudevan, Bhanumathi, P., and Saleesh, E. D., “WR-1065 as a chemoprotector in Adriamycin chemotherapy”, Cancer Letters, vol. 81, pp. 171-175, 1994.